Search Results - "Domínguez‐Rodríguez, Juan Francisco"

Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain—The Fostasur Study by Jiménez‐Bárcenas, Reyes, García‐Donas‐Gabaldón, Gloria, Campos‐Álvarez, Rosa María, Fernández‐Sánchez de Mora, María Carmen, Luis‐Navarro, Josefa, Domínguez‐Rodríguez, Juan Francisco, Nieto‐Hernández, María del Mar, Sánchez‐Bazán, Irene, Yera‐Cobo, Maria, Cardesa‐Cabrera, Rocio, Jiménez‐Gonzalo, Francisco José, Ruiz‐Cobo, María Antonia, Caparrós‐Miranda, Isabel, Entrena‐Ureña, Laura, Fernández Jiménez, Dolores, Díaz‐Canales, Dana, Moreno‐Carrasco, Gloria, Calderón‐Cabrera, Cristina, Núñez‐Vázquez, Ramiro José, Pedrote‐Amador, Begoña, Mingot‐Castellano, María Eva

“…Summary Immune thrombocytopenia (ITP) is characterized by low platelet counts (PLTs) and an increased risk of bleeding. Fostamatinib, a spleen tyrosine kinase…”
Get full text

Platelet Responses After Tapering and Discontinuation of Fostamatinib in Patients with Immune Thrombocytopenia: A Continuation of the Fostasur Study by Mingot-Castellano, María Eva, García-Donas, Gloria, Campos-Álvarez, Rosa María, de Mora, María Carmen Fernández-Sánchez, Luis-Navarro, Josefa, Domínguez-Rodríguez, Juan Francisco, del Mar Nieto-Hernández, María, Sánchez-Bazán, Irene, Yera-Cobo, Maria, Cardesa-Cabrera, Rocio, Jiménez-Gonzalo, Francisco José, Caparrós-Miranda, Isabel, Entrena-Ureña, Laura, Herrera, Sergio Jurado, Fernández Jiménez, Dolores, Díaz-Canales, Dana, Moreno-Carrasco, Gloria, Calderón-Cabrera, Cristina, Núñez-Vázquez, Ramiro José, Pedrote-Amador, Begoña, Jiménez Bárcenas, Reyes

“…Background/objectives: Fostamatinib is a spleen tyrosine kinase (SYK) inhibitor approved for the treatment of adult patients with chronic immune…”
Get full text